JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of .0 million. The aggregate net proceeds to the Company from this offering are expected to be approximately .5 million, after deducting underwriting discounts and commissions and other estimated